CAS RN: 1276105-89-5
CNX-1351
Product Availability
Choose a grade to view its available package options.
1 package records 0 with current stock 1 grade group
Grade
≥99% (1)
In stock only
Batch No. Package Availability Lead Time Inquiry
Batchno.20260209
5mg / 10mg
Out of stock
5-7 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 0.25g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 1276105-89-5
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
0.25g
≥95%
0
Out of Stock
Hong Kong
Inquiry
1276105-89-5 / 1-[4-[[2-(1H-indazol-4-yl)-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl]piperazin-1-yl]-6-methylhept-5-ene-1,4-dione
Standard CAS: 1276105-89-5
Multi CAS: No
Basic Information
copy
CAS
1276105-89-5 copy
Multi CAS
No copy
Molecular Formula
C30H35N7O3S copy
Molecular Weight
573.700000 copy
Exact Mass
573.252209 copy
SMILES
CC(=CC(=O)CCC(=O)N1CCN(CC1)CC2=CC3=C(S2)C(=NC(=N3)C4=C5C=NNC5=CC=C4)N6CCOCC6)C copy
InChI
InChI=1S/C30H35N7O3S/c1-20(2)16-21(38)6-7-27(39)36-10-8-35(9-11-36)19-22-17-26-28(41-22)30(37-12-14-40-15-13-37)33-29(32-26)23-4-3-5-25-24(23)18-31-34-25/h3-5,16-18H,6-15,19H2,1-2H3,(H,31,34) copy
InChIKey
DLNUPKDFXMWRFP-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
41 copy
Aromatic heavy atom count
18 copy
Fraction Csp3
0.43 copy
Rotatable bonds
8 copy
H-bond acceptors
9 copy
H-bond donors
1 copy
Molar refractivity
161.06 copy
TPSA
107.55 copy
LogP / Solubility
WLOGP
4.03 copy
MLOGP
3.59 copy
XLogP3
2.9 copy
Consensus LogP
3.51 copy
Log S (ESOL)
-5.73 copy
Class (ESOL)
Slightly soluble copy
Log S (Ali)
-7.17 copy
Class (Ali)
Insoluble copy
Log S (SILICOS-IT)
-7.69 copy
Class (SILICOS-IT)
Insoluble copy
ADME
GI absorption
High copy
BBB permeant
No copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
Yes copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
Yes copy
CYP3A4 inhibitor
Yes copy
Log Kp (skin permeation)
-3.36 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Brenk alerts
1 copy
Leadlikeness
No copy
Synthetic Accessibility
5.5 copy